MedPath

Neurothrombectomy France

Completed
Conditions
Cerebral Artery Occlusion
Registration Number
NCT02880579
Lead Sponsor
Nantes University Hospital
Brief Summary

The Ischemic Brain Vascular Accident (CVA) is a major public health issue. An Early and appropriate charging anyone with stroke is essential to reduce mortality, reduce dependency and promote recovery of autonomy. Intravenous fibrinolysis in patients with cerebral infarction (NINDS 1995), is reserved for a small proportion of highly selected patients. It therefore remains a significant therapeutic challenge, especially for patients with against-indications to fibrinolysis or in whom there is no immediate benefit. For twenty years of mechanical devices have been developed to remove, as quickly as possible, the cause of intracranial arterial occlusion and allow restoration of blood flow before brain damage is irreversible.

NTF The protocol is part of the evaluation process of our clinical practices recommended by the National Health Authority (HAS), in the specific context of mechanical thrombectomy performed in French centers of interventional neuroradiology working with neurovascular units (A V).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
230
Inclusion Criteria
  • Signature of the information notice by the patient or his legal representative
  • Age> 18 years
  • Clinical and imaging consistent with ischemic stroke whose symptoms start back within 8h
  • Thrombosis (TICI 0 or 1) of the carotid T, M1, M1-M2 bifurcation of the basilar artery occlusion in TANDEM ACI / M1.
Read More
Exclusion Criteria
  • Pregnant or lactating women
  • Rapid improvement of NIHSS (gain of more than 4 points) between two pre-treatment assessments.
  • ASPECT score <7 on the scanner or <5 on the diffusion-weighted imaging (DWI)
  • Intracranial hemorrhage on imaging
  • Inability of clinical evaluations at 3 months
  • extensive lesions of the brain stem (the presence of a complete section of the brainstem hyperintense b1000)
  • 0 Refusal to participate in the study
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
clinical score for handicap (mRS)at 3 months
Secondary Outcome Measures
NameTimeMethod
presence of arterial hypertensionbaseline

Factors of good clinical prognosis

presence of hypercholesterolemiabaseline

Factors of good clinical prognosis

NIHSS scorebaseline

Factors of good clinical prognosis

influence of anesthesia on the NIHSSat 24h
hemorrhagic complicationsat 24h
unblocking rate based on the score TICIat 3 months
NIHSS evaluationat 24h
presence of neoplasiabaseline

Factors of good clinical prognosis

Influence of hemorrhagic complications on NIHSSat 3 months
presence of diabetesbaseline

Factors of good clinical prognosis

hemorrhagic complications on postoperative imagingat 1 day
physiological parameter : agebaseline

Factors of good clinical prognosis

presence of intracranial stenosisbaseline

Factors of good clinical prognosis

presence of haematological disordersbaseline

Factors of good clinical prognosis

ASPECTS scorebaseline

Factors of good clinical prognosis

MRI imaging of strokebaseline

Factors of good clinical prognosis

presence of coronary artery diseasebaseline

Factors of good clinical prognosis

presence of occlusive arterial diseasebaseline

Factors of good clinical prognosis

Influence of collaterality score on the NIHSSat 24h
Influence ASPECTS score on the NIHSSat 3months
© Copyright 2025. All Rights Reserved by MedPath